Concepedia

Hitomi Akazawa

HA

Statistics

Publications

4

Citations

533

H-Index

4

Active since

2014

Affiliations

Otsuka (Japan)(Current)

Otsuka (United States)

Lundbeck (Denmark)

Hitomi Akazawa is an author at Otsuka (Japan) specializing in medicine, psychopharmacology, and dopaminergic pharmacology.

Publications per year

2014–2021

4

Publications

4

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 362 citations

, , +15

Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator

Kenji Maeda, Linda Lerdrup, Haruhiko Sugino et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 130 citations

, , +17

Brexpiprazole has a low risk of dopamine D<sub>2</sub> receptor sensitization and inhibits rebound phenomena related to D<sub>2</sub> and serotonin 5‐HT<sub>2A</sub> receptors in rats

Naoki Amada, Hitomi Akazawa, Yuta Ohgi et al. · Neuropsychopharmacology Reports · 2019 · 24 citations · Full text

, , +17

Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human

Hiroyuki Sasabe, Toshihisa Koga, Masayuki Furukawa et al. · Xenobiotica · 2021 · 17 citations · Full text

, , +16

1–4 of 4